Our Thinking - J+D Forecasting Blog

How to forecast in a Covid-19 world?

14th September 2020

The COVID-19 pandemic has brought fast moving, changing variables placing extraordinary strains and uncertainty on society as whole. The changes in primary and secondary care globally have and will continue to affect future pharmaceutical forecasts for in-market and new product launches. High levels of unpredictability…

J+D Forecasting strike the balance between simplicity and complexity when modelling for the liquid tumour market

12th August 2020

J+D’s approach and the model has given the team greater confidence in the outputs and subsequent decisions they will have to make in taking the product forward.

J+D Forecasting Changed the Forecasting Approach of a Global Bio Tech Forever

23rd July 2020

One of the world’s first global biotechnology companies a leader, in innovative scientific research in neurological diseases approached J+D Forecasting with a set of forecasting challenges.

Improve efficiencies in your long-range/strategic planning

21st July 2020

Here we offer insight into how you can improve efficiencies in your long range strategic planning by moving to cloud-based software solutions.

Best practice tips for visualizing your pharma forecast

20th July 2020

Here we offer insight into the best practises for visualising your forecast, from thinking about your audience to interacting with data.

How to choose the most appropriate trending approach for a sales forecast

18th June 2020

When you are creating a sales-based forecast there can be a wide range of sophisticated forecasting methodologies available to you.

Forecasting by biomarker, not tumour type

18th June 2020

If you are forecasting for an asset across multiple tumour types, forecasting using biomarkers may be a favourable approach for you.

The Unique Challenges and Opportunities of Forecasting for Orphan Diseases

15th June 2020

An article written by David James, IPI - International Pharmaceutical Industry

Running a risk analysis on consolidated revenues

15th June 2020

This post will look at Epidemiology Forecasting, and running a risk analysis on consolidated revenues.

Accounting for chronic patients in your forecast

15th June 2020

This post will look at Oncology Forecasting, and accounting for chronic patients in your forecast.

Linking an NPV to your sales forecast

15th April 2020

Learn how to link your forecast to a Profit & Loss account, determining Net Present Value can make for much better evaluation of opportunities.

Top 5 forecasting tips in Oncology

Contact us for a consultation Find more J+D Forecasting insights 1 – All Change Consider the stability of the market when deciding on the methodology. Patient flow models are accurate and provide a great deal of insight, however, they’re only really necessary when there is…